Authors retract highly cited 2014 Science paper

The authors of a 2014 paper in Science have retracted it, after becoming aware that impurities in the chemicals they used for their experiments may have generated the apparent findings.

The paper, “Ammonia synthesis by N2 and steam electrolysis in molten hydroxide suspensions of nanoscale Fe2O3,” has been cited 323 times, according to Clarivate Analytics’ Web of Science, earning it a “hot paper” designation. According to a summary of the work, “the protocol points to a way to produce ammonia from purely renewable resources.”

Here’s the retraction notice:

Continue reading Authors retract highly cited 2014 Science paper

Author retracts Nature commentary over concerns about section’s sponsorship

Kenneth Witwer

Nature has retracted a recent commentary after the author complained that he had been misled by the relationship of the publication to a financial sponsor and told to avoid critiquing work from the institution. The journal says it is revisiting its “editorial guidelines and processes” in the wake of the case. 

Kenneth Witwer, an RNA expert at Johns Hopkins University in Baltimore, said he had been approached by Nature earlier this year to contribute a piece to one of the journal’s “Outlook” sections.  

Outlook sections are sponsored, and in this case, the supporter was Nanjing University in China. One of the institution’s deans and star researchers, Chen-Yu Zhang, had arranged the section and written an article for it as well — a piece Witwer described as essentially an advertorial for Zhang’s questionable research. [Springer Nature, in comments to Retraction Watch, said that “The Zhang piece is advertorial, is clearly labelled as such and uses a different typeface from editorial content to promote transparency.”]

According to Nature policy

Continue reading Author retracts Nature commentary over concerns about section’s sponsorship

A big Nature study on a tiny dinosaur is being retracted

A paper on a pocket-sized winged “dinosaur” is being retracted after new unpublished findings cast doubt on the authors’ characterizations of their discovery.

The study, “Hummingbird-sized dinosaur from the Cretaceous period of Myanmar,” was published in Nature on March 11, 2020. Many news outlets, including the New York Times, Newsweek and National Geographic, picked up on the findings. 

Then on March 18, Zhiheng Li of the Chinese Academy of Sciences, along with co-authors, posted a comment on bioRxiv about the study, casting doubt on whether the amber-encased specimen was in fact a dinosaur or avian species.

Nature updated the study with an expression of concern on May 29, which said:

Continue reading A big Nature study on a tiny dinosaur is being retracted

“Consistently unsurprised”: Nigerian vaccine study with no Nigerian authors retracted

Last month, PLOS ONE published a paper reporting on a trial to improve the uptake of the measles vaccine in Nigeria. The researchers were affiliated with IDinsight, a San Francisco-based “global advisory, data analytics, and research organization that helps development leaders maximize their social impact.”

San Francisco is about 7,800 miles from Lagos, and the list of authors — Sam Brownstone, Alison Connor and Daniel Stein, a former economist at the World Bank — seemed suspiciously devoid of Nigerian names.  

That omission was even more strange given the title of the article: “Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake.” Almost immediately after publication, Ejemai Eboreime, a physician and public health worker, pointed out on Twitter the implausibility of the implied claim that no local scientists were involved in a randomized controlled trial covering nine clinics throughout the country — which he alleged also was a violation of local research ethics provisions. 

Continue reading “Consistently unsurprised”: Nigerian vaccine study with no Nigerian authors retracted

Authors of study on race and police killings ask for its retraction, citing “continued misuse” in the media

via Tony Webster/Flickr

The authors of a controversial paper on race and police shootings say they are retracting the article, which became a flashpoint in the debate over killings by police, and now amid protests following the murder of George Floyd.

[See an update on this post.]

The 2019 article in the Proceedings of the National Academy of Sciences (PNAS), titled “Officer characteristics and racial disparities in fatal officer-involved shootings,” found “no evidence of anti-Black or anti-Hispanic disparities across shootings, and White officers are not more likely to shoot minority civilians than non-White officers.” It has been cited 14 times, according to Clarivate Analytics’ Web of Science, earning it a “hot paper” designation.

Joseph Cesario, a researcher at Michigan State University, told Retraction Watch that he and David Johnson, of the University of Maryland, College Park and a co-author, have submitted a request for retraction to PNAS. In the request, they write:

Continue reading Authors of study on race and police killings ask for its retraction, citing “continued misuse” in the media

Drug delivery study with duplicated images is retracted

By Elisabeth Bik, via PubPeer

A study that found a way to deliver certain kinds of drugs more effectively in mice is being retracted today.

The study, “Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide” was overseen by Haifa Shen at the Houston Methodist Research Institute and published in Science Advances on April 1.

Several readers, including scientific sleuth Elisabeth Bik, posted concerns about the article’s images on PubPeer within weeks of the paper’s publication. The concerns involved overlapping and duplicate images, and this gem:

Could the authors clarify if some of the mice had two sets of major organs, please?

The retraction notice says:

Continue reading Drug delivery study with duplicated images is retracted

Figure “anomalies” prompt Harvard group to retract Nature paper

A group of researchers based at Harvard Medical School have retracted their 2019 paper in Nature after a data sleuth detected evidence of suspect images in the article. 

The move comes ten months after the journal first heard from the sleuth, Elisabeth Bik.

The paper, “Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation,” came from the lab of Xu Wu, of the Cutaneous Biology Research Center at Massachusetts General Hospital, and his colleagues. It appeared last August — and immediately caught the attention of Rune Linding, who flagged it for Bik, who in turn noticed several regions of concerning duplications in a few of the Western blots that appeared in the paper. 

On August 29 of last year, Bik tweeted:

Continue reading Figure “anomalies” prompt Harvard group to retract Nature paper

JAMA journal retracts well-publicized paper linking doctor burnout to patient safety

Source

A JAMA journal has retracted a 2018 paper linking physician burnout to poor patient care, after a misconduct inquiry found evidence of shoddy work but not data fabrication.

The article, “Association between physician burnout and patient safety, professionalism, and patient satisfaction: a systematic review and meta-analysis,” was published in JAMA Internal Medicine by a group based at the National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, in England. The journal also published a commentary on the article and three letters to the editor, which have been flagged to indicate the new retraction.

The paper — which concluded that burned-out doctors might be jeopardizing the well-being of their patients — received a significant amount of coverage in the media, with stories trumpeting the take-home message that: 

Continue reading JAMA journal retracts well-publicized paper linking doctor burnout to patient safety

Associate VP for research at Georgia State is up to 10 retractions

Ming-Hui Zou

The associate vice president for research at Georgia State University and founding director of the university’s Center for Molecular and Translational Medicine has had his tenth paper retracted.

Like the nine previous retractions for Ming-Hui Zou, the work underlying the newly retracted paper in PLOS ONE was performed while Zou was at Oklahoma State University.

The extensive retraction notice for “Activation of the AMP-Activated Protein Kinase (AMPK) by Nitrated Lipids in Endothelial Cells” refers to problems in six of the paper’s figures, including unexpected similarities and likely splicing. It concludes:

Continue reading Associate VP for research at Georgia State is up to 10 retractions

A whodunit: Journal retracts paper that copied from an unpublished manuscript

A journal has retracted a 2015 paper because it apparently plagiarized a manuscript submitted two years earlier — but we’re scratching our heads about how it all happened.

The paper, “Chattering-free variable structure controller design via fractional calculus approach and its application,” was published in Nonlinear Dynamics and has been cited 15 times, according to Clarivate Analytics’ Web of Science.

Here’s the notice:

Continue reading A whodunit: Journal retracts paper that copied from an unpublished manuscript